Intracisternal administration of glibenclamide or 5-hydroxydecanoate does not reverse the neuroprotective effect of ketogenic diet against ischemic brain injury-induced neurodegeneration.
about
The ketogenic diet as a treatment paradigm for diverse neurological disordersAmiloride but not memantine reduces neurodegeneration, seizures and myoclonic jerks in rats with cardiac arrest-induced global cerebral hypoxia and reperfusion.The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.
P2860
Intracisternal administration of glibenclamide or 5-hydroxydecanoate does not reverse the neuroprotective effect of ketogenic diet against ischemic brain injury-induced neurodegeneration.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Intracisternal administration ...... ury-induced neurodegeneration.
@en
Intracisternal administration ...... ury-induced neurodegeneration.
@nl
type
label
Intracisternal administration ...... ury-induced neurodegeneration.
@en
Intracisternal administration ...... ury-induced neurodegeneration.
@nl
prefLabel
Intracisternal administration ...... ury-induced neurodegeneration.
@en
Intracisternal administration ...... ury-induced neurodegeneration.
@nl
P2093
P2860
P1433
P1476
Intracisternal administration ...... ury-induced neurodegeneration.
@en
P2093
P2860
P304
P356
10.3109/02699050903421123
P577
2009-12-01T00:00:00Z